BC
IMGN

Bridgefront Capital’s Immunogen Inc IMGN Stock Holding History

Bridgefront Capital’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,509
Closed -$341K – 590
2023
Q4 		$341K Buy
+11,509
New +$229K 0.26% 145

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bridgefront Capital's IMGN Position: Q1 2024 in Review

Bridgefront Capital sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 11,509 shares — an estimated $341K sold.

Bridgefront Capital first reported a position in IMGN in Q4 2023 and held it in 1 quarter. The position peaked at $341K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Bridgefront Capital reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Bridgefront Capital sold 11,509 Immunogen Inc shares in Q1 2024, an estimated $341K.
  • Bridgefront Capital first reported a position in Immunogen Inc in Q4 2023 and held it in 1 quarter.
  • Bridgefront Capital's Immunogen Inc position peaked at $341K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Bridgefront Capital's 13F filing for Q1 2024, filed 15 May 2024.